Cargando…

Immunological Profile of Silent Brain Infarction and Lacunar Stroke

Neuroinflammation is believed to be involved in the pathophysiological mechanisms of silent brain infarcts (SBI). However, the immunological profile of SBI has been scarcely investigated. In the context of a national research project named SILENCE, aimed at investigating clinical, biochemical and pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarchielli, Paola, Nardi, Katiuscia, Chiasserini, Davide, Eusebi, Paolo, Tantucci, Michela, Di Piero, Vittorio, Altieri, Marta, Marini, Carmine, Russo, Tommasina, Silvestrini, Mauro, Paolino, Isabella, Calabresi, Paolo, Parnetti, Lucilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706426/
https://www.ncbi.nlm.nih.gov/pubmed/23874624
http://dx.doi.org/10.1371/journal.pone.0068428
_version_ 1782476558763556864
author Sarchielli, Paola
Nardi, Katiuscia
Chiasserini, Davide
Eusebi, Paolo
Tantucci, Michela
Di Piero, Vittorio
Altieri, Marta
Marini, Carmine
Russo, Tommasina
Silvestrini, Mauro
Paolino, Isabella
Calabresi, Paolo
Parnetti, Lucilla
author_facet Sarchielli, Paola
Nardi, Katiuscia
Chiasserini, Davide
Eusebi, Paolo
Tantucci, Michela
Di Piero, Vittorio
Altieri, Marta
Marini, Carmine
Russo, Tommasina
Silvestrini, Mauro
Paolino, Isabella
Calabresi, Paolo
Parnetti, Lucilla
author_sort Sarchielli, Paola
collection PubMed
description Neuroinflammation is believed to be involved in the pathophysiological mechanisms of silent brain infarcts (SBI). However, the immunological profile of SBI has been scarcely investigated. In the context of a national research project named SILENCE, aimed at investigating clinical, biochemical and pathogenic features of SBI, we have measured the plasma profile of some inflammatory-related molecules in SBI patients (n = 21), patients with recent lacunar infarcts (LI, n = 28) and healthy controls (n = 31), consecutively enrolled in four Italian centres. A panel of chemokines (MIG, CTACK, IL16, SDF1a, MCP1), growth factors (SCF, SCGFb, HGF, IL3), immunoglobulin-type adhesion molecules (ICAM1, VCAM1), proinflammatory cytokines (IL18, INFa2, MIF, IL12p40), cell surface receptors on T-cells (IL2Ra), and inductors of apoptosis (TRAIL) was assessed in plasma samples by Luminex xMAP™ technology. Immunological parameters were compared using non-parametric statistics and performance to distinguish SBI and LI was evaluated by receiver operating characteristic (ROC) analysis. Plasma levels of ICAM1 were significantly higher in both SBI and LI patients as compared to controls (SBI≥LI>Ctrl). A different trend was observed for IL16 (SBI<LI>Ctrl), SCF (LI<SBI>Ctrl) and SCGFb (SBI>LI<Ctrl). SBI subjects had significantly increased levels of MIG when compared to controls (LI≤SBI>Ctrl) and IL18 when compared to LI patients (Ctrl≤SBI>LI). All the other immunological markers did not significantly differ among groups. According to ROC analysis, the best predictor for SBI condition was the chemokine MIG (AUC = 0.84, sensitivity 86%, specificity 77%), while SCF had the best performance in distinguishing LI patients (AUC = 0.84, sensitivity 86%, specificity 68%). These results confirm the involvement of inflammatory processes in cerebrovascular disorders, particularly in SBI, a very common age-related condition. The differences in plasma profile of inflammatory molecules may underlie different pathological mechanisms in SBI and LI patients.
format Online
Article
Text
id pubmed-3706426
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37064262013-07-19 Immunological Profile of Silent Brain Infarction and Lacunar Stroke Sarchielli, Paola Nardi, Katiuscia Chiasserini, Davide Eusebi, Paolo Tantucci, Michela Di Piero, Vittorio Altieri, Marta Marini, Carmine Russo, Tommasina Silvestrini, Mauro Paolino, Isabella Calabresi, Paolo Parnetti, Lucilla PLoS One Research Article Neuroinflammation is believed to be involved in the pathophysiological mechanisms of silent brain infarcts (SBI). However, the immunological profile of SBI has been scarcely investigated. In the context of a national research project named SILENCE, aimed at investigating clinical, biochemical and pathogenic features of SBI, we have measured the plasma profile of some inflammatory-related molecules in SBI patients (n = 21), patients with recent lacunar infarcts (LI, n = 28) and healthy controls (n = 31), consecutively enrolled in four Italian centres. A panel of chemokines (MIG, CTACK, IL16, SDF1a, MCP1), growth factors (SCF, SCGFb, HGF, IL3), immunoglobulin-type adhesion molecules (ICAM1, VCAM1), proinflammatory cytokines (IL18, INFa2, MIF, IL12p40), cell surface receptors on T-cells (IL2Ra), and inductors of apoptosis (TRAIL) was assessed in plasma samples by Luminex xMAP™ technology. Immunological parameters were compared using non-parametric statistics and performance to distinguish SBI and LI was evaluated by receiver operating characteristic (ROC) analysis. Plasma levels of ICAM1 were significantly higher in both SBI and LI patients as compared to controls (SBI≥LI>Ctrl). A different trend was observed for IL16 (SBI<LI>Ctrl), SCF (LI<SBI>Ctrl) and SCGFb (SBI>LI<Ctrl). SBI subjects had significantly increased levels of MIG when compared to controls (LI≤SBI>Ctrl) and IL18 when compared to LI patients (Ctrl≤SBI>LI). All the other immunological markers did not significantly differ among groups. According to ROC analysis, the best predictor for SBI condition was the chemokine MIG (AUC = 0.84, sensitivity 86%, specificity 77%), while SCF had the best performance in distinguishing LI patients (AUC = 0.84, sensitivity 86%, specificity 68%). These results confirm the involvement of inflammatory processes in cerebrovascular disorders, particularly in SBI, a very common age-related condition. The differences in plasma profile of inflammatory molecules may underlie different pathological mechanisms in SBI and LI patients. Public Library of Science 2013-07-09 /pmc/articles/PMC3706426/ /pubmed/23874624 http://dx.doi.org/10.1371/journal.pone.0068428 Text en © 2013 Sarchielli et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sarchielli, Paola
Nardi, Katiuscia
Chiasserini, Davide
Eusebi, Paolo
Tantucci, Michela
Di Piero, Vittorio
Altieri, Marta
Marini, Carmine
Russo, Tommasina
Silvestrini, Mauro
Paolino, Isabella
Calabresi, Paolo
Parnetti, Lucilla
Immunological Profile of Silent Brain Infarction and Lacunar Stroke
title Immunological Profile of Silent Brain Infarction and Lacunar Stroke
title_full Immunological Profile of Silent Brain Infarction and Lacunar Stroke
title_fullStr Immunological Profile of Silent Brain Infarction and Lacunar Stroke
title_full_unstemmed Immunological Profile of Silent Brain Infarction and Lacunar Stroke
title_short Immunological Profile of Silent Brain Infarction and Lacunar Stroke
title_sort immunological profile of silent brain infarction and lacunar stroke
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706426/
https://www.ncbi.nlm.nih.gov/pubmed/23874624
http://dx.doi.org/10.1371/journal.pone.0068428
work_keys_str_mv AT sarchiellipaola immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT nardikatiuscia immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT chiasserinidavide immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT eusebipaolo immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT tantuccimichela immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT dipierovittorio immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT altierimarta immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT marinicarmine immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT russotommasina immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT silvestrinimauro immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT paolinoisabella immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT calabresipaolo immunologicalprofileofsilentbraininfarctionandlacunarstroke
AT parnettilucilla immunologicalprofileofsilentbraininfarctionandlacunarstroke